Share

May 6, 2008; 70 (19)

Share

A

  1. Anderson, David C.

    1. Thinking outside the boxNINDS and the Clinical Research Collaboration
      David C. Anderson

  2. Argoff, C. E.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

B

  1. Bartolomei, F.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  2. Becker, J. T.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  3. Benito-León, Julián

    1. Population-based prospective study of cigarette smoking and risk of incident essential tremor
      Elan D. Louis, Julián Benito-León, Félix Bermejo-Pareja

  4. Bermejo-Pareja, Félix

    1. Population-based prospective study of cigarette smoking and risk of incident essential tremor
      Elan D. Louis, Julián Benito-León, Félix Bermejo-Pareja

  5. Bezzi, G.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

  6. Blitzer, A.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  7. Brashear, A.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

C

  1. Cerri, F.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

  2. Chang, Y. F.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  3. Chauvel, P.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  4. Childers, M. K.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  5. Cho, Tracey A.

    1. Education Research: A program perspective on learning how to teach
      Kevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho

  6. Clemons, T.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  7. Comella, C.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  8. Comi, G.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

D

  1. Dalton, A.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  2. DeKosky, S. T.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  3. Dubinsky, R.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  4. Dykstra, D. D.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

E

  1. Epis, R.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

F

  1. Felson, David T.

    1. Protective effects of NSAIDs on the development of Alzheimer disease
      Steven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson

  2. Fischer, C.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

G

  1. Gach, H. M.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  2. Gracies, J-M

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course

  3. Graham, H. K.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course

  4. Grew, S.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

  5. Gronseth, G. S.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

H

  1. Hallett, M.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  2. Hart, R. G.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  3. Hayashi, M.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  4. Hewamadduma, C.A.A.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

J

  1. Jabbari, B.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  2. Jankovic, J.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  3. Johnson, Lorraine

    1. PRACTICE PARAMETER: TREATMENT OF NERVOUS SYSTEM LYME DISEASE (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY
      Raphael B. Stricker, Lorraine Johnson

K

  1. Karp, B.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

  2. Kaufmann, H. C.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  3. Kershaw, C.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  4. Kirby, J.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  5. Kowall, Neil W.

    1. Protective effects of NSAIDs on the development of Alzheimer disease
      Steven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson

  6. Kuller, L. H.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

L

  1. Lindblad, A. S.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  2. Lindblad, R. W.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  3. Lopez, O. L.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  4. Louis, Elan D.

    1. Population-based prospective study of cigarette smoking and risk of incident essential tremor
      Elan D. Louis, Julián Benito-León, Félix Bermejo-Pareja

  5. Ludlow, C. L.

    1. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

M

  1. Magdelaine, C.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

  2. Martindale, J.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  3. Mascitelli, Luca

    1. STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDY
      Luca Mascitelli, Francesca Pezzetta

  4. McDermott, C. J.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  5. Meador, K. J.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  6. Mehta, P. D.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  7. Meyer, Tanya

    1. Teaching Video NeuroImage: Spasmodic dysphoniaAdductor and abductorGraphic
      Stephen G. Reich, Tanya Meyer

  8. Miller, Donald R.

    1. Protective effects of NSAIDs on the development of Alzheimer disease
      Steven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson

  9. Miyasaki, J. M.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course
    2. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course

N

  1. Naumann, M.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course
    2. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course
    3. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  2. Nemni, R.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

  3. Nicholson, G. A.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

O

  1. Odenkirchen, J. C.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

  2. Ouvrier, R. A.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

P

  1. Pezzetta, Francesca

    1. STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDY
      Luca Mascitelli, Francesca Pezzetta

  2. Ponzoni, M.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

  3. Previtali, S. C.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

Q

  1. Quattrini, A.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

R

  1. Régis, J.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  2. Reich, Stephen G.

    1. Teaching Video NeuroImage: Spasmodic dysphoniaAdductor and abductorGraphic
      Stephen G. Reich, Tanya Meyer

  3. Rey, M.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  4. Riva, N.

    1. LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
      N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, A. Quattrini

  5. Russman, B.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course

  6. Ryan, M. M.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

S

  1. Schurch, B.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  2. Shaw, P. J.

    1. HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER
      C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, P. J. Shaw

  3. Sheth, Kevin N.

    1. Education Research: A program perspective on learning how to teach
      Kevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho

  4. Silberstein, S. D.

    1. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  5. Simpson, D. M.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course
    2. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course
    3. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  6. Simpson, L. L.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course

  7. So, Y.

    1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      D. M. Simpson, J-M Gracies, H. K. Graham, J. M. Miyasaki, M. Naumann, B. Russman, L. L. Simpson, Y. So
      CME Course
    2. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyGraphic
      D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, Y. So
      CME Course
    3. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
      M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra, G. S. Gronseth, B. Jabbari, H. C. Kaufmann, B. Schurch, S. D. Silberstein, D. M. Simpson

  8. Spencer, Susan S.

    1. Gamma knife radiosurgery for refractory medial temporal lobe epilepsyToo little, too late?
      Susan S. Spencer

  9. Stricker, Raphael B.

    1. PRACTICE PARAMETER: TREATMENT OF NERVOUS SYSTEM LYME DISEASE (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY
      Raphael B. Stricker, Lorraine Johnson

  10. Sturtz, F.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

  11. Sweet, R. A.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

  12. Sykes, R.

    1. Applicability of NINDS-sponsored studies to community-based physician involvementGraphic
      A. S. Lindblad, T. Clemons, R. W. Lindblad, R. Sykes, K. J. Meador, J. C. Odenkirchen, R. G. Hart

T

  1. Tamura, M.

    1. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsyGraphic
      F. Bartolomei, M. Hayashi, M. Tamura, M. Rey, C. Fischer, P. Chauvel, J. Régis

  2. Tracy, R.

    1. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
      O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, S. T. DeKosky

V

  1. Vallat, J. -M.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

  2. Vlad, Steven C.

    1. Protective effects of NSAIDs on the development of Alzheimer disease
      Steven C. Vlad, Donald R. Miller, Neil W. Kowall, David T. Felson

  3. Vossel, Keith A.

    1. Education Research: A program perspective on learning how to teach
      Kevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho

W

  1. Wijdicks, Eelco F.M.

    1. Plantar flexion and flexion synergy in brain deathGraphic
      Alexander Y. Zubkov, Eelco F.M. Wijdicks

Y

  1. Yu, Timothy W.

    1. Education Research: A program perspective on learning how to teach
      Kevin N. Sheth, Timothy W. Yu, Keith A. Vossel, Tracey A. Cho

Z

  1. Zhu, D.

    1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations
      G. A. Nicholson, C. Magdelaine, D. Zhu, S. Grew, M. M. Ryan, F. Sturtz, J. -M. Vallat, R. A. Ouvrier

  2. Zubkov, Alexander Y.

    1. Plantar flexion and flexion synergy in brain deathGraphic
      Alexander Y. Zubkov, Eelco F.M. Wijdicks
Back to top
Subscribe to e-Alerts
RSS
Advertisement
Advertisement